J. Hirmerová

发表

Association Between Preexisting Versus Newly Identified Atrial Fibrillation and Outcomes of Patients With Acute Pulmonary Embolism

F. Pomero, L. Mazzolai, P. Prandoni, 2021, Journal of the American Heart Association.

Thrombophilia Work-up in Females with Venous Thromboembolism in Association with Oral Contraceptive Use: Results, Strategy and Clinical Application of Testing

M. Beranek, P. Sadílek, P. Dulíček, 2017 .

The Prevalence of Concomitant Deep Vein Thrombosis, Symptomatic or Asymptomatic, Proximal or Distal, in Patients With Symptomatic Pulmonary Embolism

J. Seidlerová, J. Hirmerová, Z. Chudáček, 2018, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Analysis of Risk Factors of Stroke and Venous Thromboembolism in Females With Oral Contraceptives Use

P. Žák, M. Beranek, P. Sadílek, 2018, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Coagulopathy associated with COVID-19.

Simona Bílková, J. Hirmerová, 2020, Vnitrni lekarstvi.

Heparin-induced thrombocytopenia treated with fondaparinux: single centre experience.

P. Sadílek, P. Dulíček, M. Košťál, 2019, International angiology : a journal of the International Union of Angiology.

Two cases of congenital dysfibrinogenemia associated with thrombosis – Fibrinogen Praha III and Fibrinogen Plzeň

P. Salaj, J. Dyr, T. Riedel, 2009, Thrombosis and Haemostasis.

The prevalence of cancer in patients with superficial vein thrombosis and its clinical importance.

J. Seidlerová, J. Hirmerová, I. Šubrt, 2021, Journal of vascular surgery. Venous and lymphatic disorders.

Unprovoked or provoked venous thromboembolism: not the prevalent criterion to decide on anticoagulation extension in clinical practice of various countries—the prospective, international, observational WHITE study

Tao Yang, Xiao-qiang Li, A. Bignamini, 2021, Internal and Emergency Medicine.

Clinical outcomes during anticoagulant therapy in fragile patients with venous thromboembolism

F. Dentali, G. Lessiani, L. Mazzolai, 2017, Research and practice in thrombosis and haemostasis.

Fragile patients with venous thromboembolism. What did we learn from RIETE.

P. Prandoni, M. Monreal, I. Mahé, 2015 .

Fragile Patients With Venous

P. Prandoni, M. Monreal, I. Mahé, 2015 .

Antithrombotic therapy in antiphospholipid syndrome, the role of direct oral anticoagulants

J. Hirmerová, 2022, Klinická farmakologie a farmacie.

Anticoagulant therapy for venous thromboembolism in patients with inflammatory bowel disease

M. Monreal, A. Merah, I. Casado, 2018, European journal of gastroenterology & hepatology.

D‐dimer levels and risk of recurrence following provoked venous thromboembolism: findings from the RIETE registry

P. Prandoni, L. Bertoletti, P. Verhamme, 2020, Journal of internal medicine.

Anticoagulation therapy - what a pharmacist should know

J. Hirmerová, 2021, Praktické lékárenství.

First three months of anticoagulation for venous thromboembolism in non-cancer patients: LMWH VS. VKAs. Findings from the RIETE registry

L. Mazzolai, P. Prandoni, E. Grandone, 2020 .

Anticoagulation therapy in cancer associated thromboembolism - new studies, new guidelines.

J. Hirmerová, 2020, Vnitrni lekarstvi.

[Two perspectives on venous thromboembolism in oncology].

P. Palacka, J. Hirmerová, 2018, Vnitrni lekarstvi.

Thrombophilias - to test or not to test?

J. Hirmerová, 2019, Interní medicína pro praxi.

The association of factor V Leiden with various clinical patterns of venous thromboembolism-the factor V Leiden paradox.

J. Seidlerová, J. Hirmerová, I. Šubrt, 2014, QJM : monthly journal of the Association of Physicians.

the factor V Leiden paradox

J. Hirmerová, I. Šubrt, Jitka Mlíková-Seidlerová, 2014 .

Laboratory Evaluation of Antiphospholipid Antibodies in Patients With Venous Thromboembolism

J. Filipovský, O. Mayer, J. Seidlerová, 2010, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Deep vein thrombosis and/or pulmonary embolism concurrent with superficial vein thrombosis of the legs: cross-sectional single center study of prevalence and risk factors.

J. Seidlerová, J. Hirmerová, I. Šubrt, 2013, International angiology : a journal of the International Union of Angiology.

The possibilities of using new (direct) oral anticoagulants in oncology

J. Hirmerová, 2020 .

Risk factors for residual thrombotic occlusion after proximal deep vein thrombosis of the legs.

J. Filipovský, J. Seidlerová, J. Hirmerová, 2010, International angiology : a journal of the International Union of Angiology.

Liver status and outcomes in patients without previous known liver disease receiving anticoagulant therapy for venous thromboembolism

P. Prandoni, L. Bertoletti, P. Verhamme, 2021, Internal and Emergency Medicine.

Percutaneous coronary intervention in a patient with immune thrombocytopenia purpura

E. Ohman, G. Stouffer, R. Simpson, 2004, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Pharmacotherapy of the symptoms of chronic venous insufficiency

J. Hirmerová, 2018, Interní medicína pro praxi.

Homocysteine and venous thromboembolism—Is there any link?

J. Hirmerová, Jana Hirmerová, 2013 .

Venous thromboembolism in young adults: Findings from the RIETE registry.

M. Monreal, B. Bikdeli, G. Tiberio, 2019, European journal of internal medicine.

Comparison of seven prognostic tools to identify low-risk pulmonary embolism in patients aged <50 years

F. Dentali, L. Mazzolai, P. Prandoni, 2019, Scientific Reports.

Development of a Risk Prediction Score for Occult Cancer in Patients With VTE

L. Mazzolai, P. Prandoni, P. Vicente, 2017, Chest.

Portal and mesenteric vein thromboses in a patient with prothrombin G20210 mutation, elevated lipoprotein (a), and high factor VIII.

V. Liska, V. Treska, H. Mírka, 2008, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Homocysteine and venous thromboembolism—Is there any link?

J. Hirmerová, 2013 .

COVID-19–associated venous thromboembolism: risk of recurrence and major bleeding

L. Jara-Palomares, A. Maestre, G. Vidal, 2023, Research and Practice in Thrombosis and Haemostasis.

A prognostic score to identify low-risk outpatients with acute deep vein thrombosis in the lower limbs.

L. Mazzolai, M. Monreal, G. Barillari, 2015, The American journal of medicine.